Haemophilus influenzae

Guidance on Haemophilus influenzae can be found below:

• For more information on Haemophilus influenzae type b (Hib) immunisation, including updates, please refer to the Public Health England (PHE) Green Book, Chapter 16.
• Find out about Public Health England's management of Hib.
• Training and educational materials for healthcare professionals are on the NHS Education for Scotland (NES) website.

In 1992, following introduction of the Hib vaccine for young children, the number of H. influenzae type b cases fell dramatically, not only in the vaccinated group but also in older age groups.  Due to reduced carriage of the organism within the respiratory tract of vaccinated children, transmission to the wider community was effectively suppressed. The addition of the Hib booster vaccine in 2006, reduced case numbers further.

In Scotland, typing is conducted on  all cases with positive laboratory reports for H. influenzae, in order that national trends in disease subtypes can be monitored. Further enhanced surveillance is carried out for all H. influenzae cases identified in children under the age of 5 and type b strains across all age groups.

Eight cases of invasive H.influenzae were reported in the third quarter of 2020, bringing the total for January to September (weeks 1 to 39) to 40. This is lower than the cumulative case numbers reported for the same period in the previous four years (range 52 to 74), as shown in Figure 1.

Figure 1: Cumulative number of Haemophilus influenzae cases reported to HPS, 2016 to 2020 (week 39)  

Of the 40 cases reported to the end of the third quarter of 2020:

• three (7.5%) were aged under five years
• three (7.5%) were aged between five and twenty years
• five (12.5%) were aged between 21 and 40 years
• 29 (72.5%) were over 40 years of age

Of the 40 invasive cases reported so far in 2020:

• 35 (87.5%) had influenzae isolated from blood
• three (7.5%) from pleural fluid
• two (5.0%) from cerebrospinal fluid

There were no known deaths associated with H.influenzae to the end of the third quarter of 2020.

Figure 2 demonstrates the epidemiological impact of the Hib vaccine, for those aged under five (routinely vaccinated group) and for all ages (including under fives). There was a marked decrease in cases from 1992 in all age groups, followed by a rise in case numbers in the early 2000s. Case numbers decreased again following the introduction of the Hib booster vaccine, and figures have remained relatively stable since 2011.

Figure 2: Laboratory reports of invasive Haemophilus influenzae type b disease in Scotland, 1988 to 2020 (week 39)

Figure 3 presents laboratory reports by serotype, since the introduction of the Hib booster campaign in 2003.

80. influenzae typing was carried out for 32 (80.0%) isolates, of which:

• 26 (81.3%) were non-typeable (NT)
• four (12.5%) were type f
• one (3.1%) was type a
• one (3.1%) was type b

Figure 3: Laboratory reports of Haemophilus influenzae by serotype, 2003 to 2020 (week 39)